cell cultureDefiniGEN and Atelerix prevent freezing da...DefiniGEN Ltd., and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to the US without freezing them thus preventing cell damage and loss-of function. more ➔
CDMOWacker Chemie AG opens €100m RNA manufac...With the opening of a production centRE for RNA vaccines and therapeutics, German CDMO Wacker Biotech is expanding its expertise in the field of RNA active ingredients. more ➔
CROConsortium led by Evotec enters obesity dr...Drug discovery CRO Evotec SE announced has entered into a partnership with Inserm, Lille University Hospital and Inserm Transfert to screen new biomarkers and targets in obesity and metabolic diseas … more ➔
Lab automationSemarion Ltd. wins Ignite SME award at SLA...UK-based Semarion Ltd. was honoured as the most innovative company in the field of laboratory automation at SLAS Europe 2024 in Barcelona. more ➔
acquisitionMSD grabs Eyebiotech Ltd for US$1.3bn upfr...US pharma giant Merck Sharp & Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones. more ➔
Lab automationSLAS Europe 2024 honours products with mo...Swiss Seed Biosciences SA and UK-based Cryologyx Ltd have won the SLAS Europe Product Award 2024 for product developments with transformational potential for the sector. more ➔
VirologyHornet Therapeutics reports first data of... Hornet Therapeutics Ltd will use a US$5m seed financing to launch clinical tests of its IDO1 blocker HTX-201within the next 12 to 18 months to target post-transplant lymphoproliferative disease. more ➔
AstraZeneca puts step into obesity marketSwiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc. more ➔
financingLabGenius raises £35m to expand its antib...London-based AI-driven antibody drug discovery specialist LabGenius Ltd has closed a £35m Series B financing round. more ➔
FinancingSeed financing for Cellugy A/SDanish industrial biotechnology startup Cellugy raises €4,9m with the ambition to replace petrochemicals in personal care products. more ➔
